GENERIC NAME: GUAIFENESIN WITH DEXTROMETHORPHAN - ORAL SPRINKLE CAPSULE (gweye-FEN-eh-sin WITH dex-trow-meth-OR-fan)
BRAND NAME(S): Humibid DM
Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage
USES: Guaifenesin is an expectorant which helps to loosen mucus. Dextromethorphan is a cough suppressant. This combination medication is used to treat a cough associated with the common cold, allergies and other respiratory illnesses.
HOW TO USE: Take this medication as prescribed. Be sure to follow instructions closely. Do not increase your dose or take this more often than directed. Sprinkle total contents of capsule on a small amount of soft food (e.g., jelly, applesauce) just before eating. Capsule contents should not be crushed or chewed. The capsule may also be swallowed whole with a full glass of water. Do not crush or chew the capsule.
SIDE EFFECTS: Headache, dizziness, loss of appetite, nausea or vomiting may occur the first several days as your body adjusts to the medication. If any of these effects continue or become bothersome, inform your doctor. Notify your doctor if you develop: a skin rash, breathing trouble. If you notice other effects not listed above, contact your doctor or pharmacist.
PRECAUTIONS: Tell your doctor if you have: lung problems (e.g., asthma, emphysema), any allergies. Use caution driving or operating machinery if this medication makes you feel dizzy. This medication should be used only if clearly needed during pregnancy. Discuss the risks and benefits with your doctor. Since small amounts of this medication are found in breast milk, consult your doctor before breast-feeding.
DRUG INTERACTIONS: Tell your doctor of any over-the-counter or prescription medication you take, especially of: MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, selegiline, tranylcypromine). Do not start or stop any medicine without doctor or pharmacist approval.
 |
 |
From the Doctors at MedicineNet.com  |
 |
Back to Medications IndexLast Editorial Review: 3/2/2005